Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Inventory (2020 - 2026)

NeuroPace has reported Inventory over the past 7 years, most recently at $16.7 million for Q1 2026.

  • For Q1 2026, Inventory rose 22.93% year-over-year to $16.7 million; the TTM value through Mar 2026 reached $16.7 million, up 22.93%, while the annual FY2025 figure was $16.9 million, 26.27% up from the prior year.
  • Inventory for Q1 2026 was $16.7 million at NeuroPace, down from $16.9 million in the prior quarter.
  • Over five years, Inventory peaked at $18.1 million in Q3 2025 and troughed at $8.1 million in Q1 2022.
  • A 5-year average of $12.1 million and a median of $11.4 million in 2024 define the central range for Inventory.
  • Biggest five-year swings in Inventory: rose 6.2% in 2024 and later soared 50.07% in 2025.
  • Year by year, Inventory stood at $9.7 million in 2022, then rose by 15.47% to $11.2 million in 2023, then grew by 19.32% to $13.4 million in 2024, then grew by 26.27% to $16.9 million in 2025, then dropped by 1.2% to $16.7 million in 2026.
  • Business Quant data shows Inventory for NPCE at $16.7 million in Q1 2026, $16.9 million in Q4 2025, and $18.1 million in Q3 2025.